​With the ageing local and global population, regenerative medicine is growing in both interest and importance. From heart and eye diseases to Alzheimer's, find out how the ongoing research and innovation work at the SingHealth Duke-NUS Regenerative Medicine Institute of Singapore (REMEDIS) promises to improve medical treatments and patient outcomes.


What is regenerative medicine?

Regenerative medicine is the science of developing therapeutics and tools to restore diseased tissues and organs.

It includes gene therapies, cell therapies, tissue engineered products and small molecules intended to augment, repair, replace or regenerate organs, tissues, cells, genes and metabolic processes in the body.

Why is it important?

Regenerative medicine is of particular importance to the ageing global population. In Singapore, the median population age has doubled over the last five decades, leading to an increase in age-related diseases of the heart, neurons and eyes, and even cancers.

Effective and accessible clinical care for these debilitating age-related conditions could also mean savings of billions of dollars that would otherwise be used to foot the bills for chronic medical care and work productivity losses.

A Hub of Regenerative Medicine: The SingHealth Duke-NUS Regenerative Medicine Institute of Singapore (REMEDIS)

The SingHealth Duke-NUS Regenerative Medicine Institute of Singapore, otherwise known as REMEDIS, was established at the SingHealth Duke- NUS Academic Medical Centre as a global centre of excellence for basic and translational research in regenerative medicine.

Singapore is equipped with extensive multidisciplinary research hubs and clinical infrastructure that are essential for cutting-edge research in regenerative medicine. By consolidating and focusing these resources through the establishment of REMEDIS, Singapore could soon be at the forefront of innovating and delivering regenerative medicine products to patients in the region and beyond.

REMEDIS will work towards its vision of 'Restoring Function and Embracing Life' in collaboration with multidisciplinary research hubs and local clinical groups.

Areas of focus for REMEDIS include regenerative therapies for:

  • Ischaemic heart disease
  • Sarcopenia
  • Neurodegenerative diseases (e.g., Alzheimer's and Parkinson disease)
  • Age-related eye diseases
  • Bone marrow disorders
  • Burns

Ongoing work by REMEDIS to advance regenerative medicine includes: